Publications

Results 2617 to 2628 of 3801
24 April 2013
The War on Drugs: Options and Alternatives

The War on Drugs: Options and Alternatives

There are a range of alternative policy models available, from increasingly punitive “zero-tolerance” enforcement, through various harm reduction strategies and options for decriminalisation of possession and use, to models for the legal regulation of drug production and supply.
24 April 2013

Count the costs: Undermining development and security, fuelling conflict

The war on drugs is actively undermining development and security in many of the world's most fragile regions and states. Drug traffickers can be more confident of a reliable, cheap supply of coca leaf, poppy or cannabis if government employees, honest politicians and armies can be kept at bay, and if farmers have few alternatives to drug production because they have little access to alternative sources of credit, and have to pay high prices to transport fertilizer or ship bulkier non-drug crops to market. As a result, traffickers prefer it if there is little economic infrastructure or governance in producing and transit areas. So they target weak states through equipping private armies, financing or merging with separatist and insurgent groups, and simultaneously corrupting politicians, police, judiciary, armed forces and customs officers. Key examples include the internal armed conflicts in Colombia and Afghanistan. Once an area is sufficiently destabilised, it deters investment by indigenous or external businesses and restricts the activities of international development NGOs and other bodies. It also diverts large amounts of valuable aid and other resources from health or development efforts into enforcement – often through the military, which can undermine accountability. The same corrosive consequences for health, governance, public authority, and democracy are replicated as traffickers trans-ship heroin, cocaine and cannabis through the Caribbean, Central America, Central Asia and West Africa. Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.